Chas P. Smith & Associates (CPS)’s Teva Pharmaceuticals TEVA Stock Holding History

Chas P. Smith & Associates (CPS)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-162,243	Closed	-$10.1M	–	104
2015 Q1	$10.1M	Sell	162,243 -6,016	-4%	-$350K	1.81%	26
2014 Q4	$9.68M	Sell	168,259 -11,040	-6%	-$615K	1.75%	27
2014 Q3	$9.64M	Sell	179,299 -3,013	-2%	-$160K	1.91%	26
2014 Q2	$9.56M	Sell	182,312 -630,744	-78%	-$32.2M	1.94%	27
2014 Q1	$43M	Buy	813,056 +28,895	+4%	+$1.34M	3.17%	8
2013 Q4	$31.4M	Buy	784,161 +531,074	+210%	+$20.9M	2.43%	17
2013 Q3	$9.56M	Buy	253,087 +4,603	+2%	+$180K	2.44%	19
2013 Q2	$9.74M	Buy	+248,484	New	+$9.68M	2.59%	14

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Chas P. Smith & Associates (CPS)'s TEVA Position: Q2 2015 in Review

Chas P. Smith & Associates (CPS) sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 162,243 shares — an estimated $10.1M sold.

Chas P. Smith & Associates (CPS) first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $43M in Q1 2014. 819 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

Chas P. Smith & Associates (CPS) reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Chas P. Smith & Associates (CPS) sold 162,243 Teva Pharmaceuticals shares in Q2 2015, an estimated $10.1M.
Chas P. Smith & Associates (CPS) first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Chas P. Smith & Associates (CPS)'s Teva Pharmaceuticals position peaked at $43M in Q1 2014.
819 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Chas P. Smith & Associates (CPS)'s 13F filing for Q2 2015, filed 29 Jul 2015.